Related Experiment Video
Updated: May 5, 2026
Intraoperative Gastroscopy for Tumor Localization in Laparoscopic Surgery for Gastric Adenocarcinoma
Published on: August 9, 2016
Artificial intelligence in gastrointestinal cancers: Diagnostic, prognostic, and surgical strategies
Ganji Purnachandra Nagaraju1, Tatekalva Sandhya2, Mundla Srilatha3
1School of Medicine, Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL, 35233, USA.
Abstract:
GI (Gastrointestinal) malignancies are one of the most common and lethal cancers globally. The dawn of precision medicine and developing technologies have reduced the mortality rates for GI malignancies, underscoring the main role of early detection methods for survival rate improvement. Artificial intelligence (AI) is a new technology that may improve GI cancer screening, treatment, and therapeutic efficiency for better patient care. AI could accelerate the development of targeted therapies by analyzing considerable data from the genome and identifying biomarkers connected with GI tumors. This opens up new avenues toward more tailored and personalized approaches, raising efficacy while reducing undesired side effects. For instance, AI may improve treatment outcomes by accurately predicting patient responses to therapeutic regimens, helping oncologists choose the most effective treatment options. This review will outline the transformative potential of AI in GI oncology by emphasizing the incorporation of AI-based technologies to enhance patient care.
Insights
Artificial intelligence (AI) can enhance gastrointestinal (GI) cancer care by improving early detection, personalizing treatments through genomic data analysis, and predicting patient responses. This technology offers a transformative approach to improving survival rates and patient outcomes in GI oncology.
Area of Science:
- Oncology
- Biotechnology
- Medical Informatics
Background:
- Gastrointestinal (GI) malignancies represent a significant global health burden, contributing to high cancer mortality rates worldwide.
- Advances in precision medicine and technology have improved survival, highlighting the critical role of early detection.
- Artificial intelligence (AI) emerges as a pivotal technology with the potential to revolutionize GI cancer care.
Purpose of the Study:
- To review the transformative potential of Artificial Intelligence (AI) in the field of Gastrointestinal (GI) oncology.
- To emphasize the integration of AI-based technologies for enhancing patient care, screening, and treatment strategies.
- To explore AI's role in accelerating targeted therapy development and personalizing treatment approaches.
Main Methods:
- Analysis of current literature on AI applications in GI oncology.
- Review of AI's capabilities in processing genomic data and identifying biomarkers.
- Examination of AI's predictive power for patient treatment responses.
Main Results:
- AI can significantly improve GI cancer screening and early detection rates.
- AI facilitates the analysis of vast genomic datasets to identify novel biomarkers for GI tumors.
- AI enhances treatment efficacy by predicting patient responses and enabling personalized therapeutic strategies, reducing side effects.
Conclusions:
- AI holds transformative potential for GI oncology, offering personalized and effective patient care.
- Integrating AI into clinical practice can lead to improved patient outcomes and survival rates for GI malignancies.
- AI-driven insights pave the way for more tailored and efficient treatment regimens in GI cancer management.
